The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen

被引:47
作者
Urbano-Ispizua, Alvaro [1 ,2 ]
Pavletic, Steven Z. [3 ]
Flowers, Mary E. [4 ]
Klein, John P. [5 ,6 ]
Zhang, Mei-Jie [5 ,6 ]
Carreras, Jeanette [5 ]
Montoto, Silvia [7 ]
Perales, Miguel-Angel [8 ]
Aljurf, Mahmoud D. [9 ]
Akpek, Goerguen [10 ]
Bredeson, Christopher N. [11 ,12 ]
Costa, Luciano J. [13 ]
Dandoy, Christopher [14 ]
Freytes, Cesar O. [15 ,16 ]
Fung, Henry C. [17 ]
Gale, Robert Peter [18 ]
Gibson, John [19 ]
Hamadani, Mehdi [5 ]
Hayashi, Robert J. [20 ]
Inamoto, Yoshihiro [4 ]
Inwards, David J. [21 ]
Lazarus, Hillard M. [22 ]
Maloney, David G. [4 ]
Martino, Rodrigo [23 ]
Munker, Reinhold [24 ]
Nishihori, Taiga [25 ]
Olsson, Richard F. [26 ,27 ]
Rizzieri, David A. [28 ]
Reshef, Ran [29 ]
Saad, Ayman [13 ]
Savani, Bipin N. [30 ]
Schouten, Harry C. [31 ]
Smith, Sonali M. [32 ]
Socie, Gerard [33 ]
Wirk, Baldeep [34 ]
Yu, Lolie C. [35 ]
Saber, Wael [5 ]
机构
[1] Univ Barcelona, Hosp Clin, IDIBAPS, Dept Hematol, Barcelona, Spain
[2] Inst Res Josep Carreras, Barcelona, Spain
[3] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[4] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[5] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA
[6] Med Coll Wisconsin, Inst Hlth & Soc, Div Biostat, Milwaukee, WI 53226 USA
[7] Barts Hlth NHS Trust, St Bartholomews Hosp, Dept Haematooncol, London, England
[8] Mem Sloan Kettering Canc Ctr, Dept Med, Bone Marrow Transplant Serv, New York, NY 10021 USA
[9] King Faisal Specialist Hosp Ctr & Res, Dept Oncol, Riyadh, Saudi Arabia
[10] Banner MD Anderson Canc Ctr, Hematol Oncol Sect, Gilbert, AZ USA
[11] Ottawa Hosp, Blood & Marrow Transplant Program, Ottawa, ON, Canada
[12] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[13] Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA
[14] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[15] South Texas Vet Hlth Care Syst, San Antonio, TX USA
[16] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[17] Temple Hlth, Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA USA
[18] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Expt Med, Hematol Res Ctr, London, England
[19] Royal Prince Alfred Hosp, Inst Haematol, Camperdown, NSW 2050, Australia
[20] Washington Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, St Louis, MO 63110 USA
[21] Mayo Clin, Div Hematol, Rochester, MN USA
[22] Univ Hosp Case Med Ctr, Seidman Canc Ctr, Cleveland, OH USA
[23] Hosp Santa Creu & Sant Pau, Div Hematol, Barcelona, Spain
[24] Louisiana State Univ Hlth, Dept Internal Med, Div Hematol Oncol, Shreveport, LA USA
[25] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Med Oncol, Tampa, FL 33612 USA
[26] Karolinska Inst, Dept Lab Med, Div Therapeut Immunol, Stockholm, Sweden
[27] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden
[28] Duke Univ, Div Hematol Malignancies & Cellular Therapy, Durham, NC USA
[29] Univ Penn, Dept Med, Abramson Canc Ctr, Med Ctr, Philadelphia, PA 19104 USA
[30] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA
[31] Acad Ziekenhuis, Dept Hematol, Maastricht, Netherlands
[32] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA
[33] Hop St Louis, Dept Hematol, Paris, France
[34] SUNY Stony Brook, Med Ctr, Dept Internal Med, Stony Brook, NY 11794 USA
[35] Louisiana State Univ, Med Ctr, Childrens Hosp, Div Hematol Oncol,Ctr Canc & Blood Disorders, New Orleans, LA USA
关键词
Graft-versus-host disease; Lymphoma; STEM-CELL TRANSPLANTATION; BONE-MARROW TRANSPLANT; ALLOGENEIC TRANSPLANTATION; HODGKINS-LYMPHOMA; EUROPEAN GROUP; BLOOD; INFUSIONS; REMISSIONS; REGISTRY;
D O I
10.1016/j.bbmt.2015.05.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to analyze the impact of graft-versus-host disease (GVHD) on the relapse rate of different lymphoma subtypes after allogeneic hematopoietic cell transplantation (allo-HCT). Adult patients with a diagnosis of Hodgkin lymphoma, diffuse large B cell lymphoma, follicular lymphoma (FL), peripheral T cell lymphoma, or mantle cell lymphoma (MCL) undergoing HLA-identical sibling or unrelated donor hematopoietic cell transplantation between 1997 and 2009 were included. Two thousand six hundred eleven cases were included. A reduced-intensity conditioning (RIC) regimen was used in 62.8% of the transplantations. In a multivariate analysis of myeloablative cases (n = 970), neither acute (aGVHD) nor chronic GVHD (cGVHD) were significantly associated with a lower incidence of relapse/progression in any lymphoma subtype. In contrast, the analysis of RIC cases (n = 1641) showed that cGVHD was associated with a lower incidence of relapse/progression in FL (risk ratio [RR],.51; P = 3.049) and in MCL (RR,.41; P = .019). Patients with FL or MCL developing both aGVHD and cGVHD had the lowest risk of relapse (RR,.14; P = .007; and RR,.15; P = .0019, respectively). Of interest, the effect of GVHD on decreasing relapse was similar in patients with sensitive disease and chemoresistant disease. Unfortunately, both aGVHD and cGVHD had a deleterious effect on treatment-related mortality and overall survival (OS) in FL cases but did not affect treatment-related mortality, OS or PFS in MCL. This study reinforces the use of RIC allo-HCT as a platform for immunotherapy in FL and MCL patients. (C) 2015 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:1746 / 1753
页数:8
相关论文
共 27 条
[1]   Defining the Intensity of Conditioning Regimens: Working Definitions [J].
Bacigalupo, Andrea ;
Ballen, Karen ;
Rizzo, Doug ;
Giralt, Sergio ;
Lazarus, Hillard ;
Ho, Vincent ;
Apperley, Jane ;
Slavin, Shimon ;
Pasquini, Marcelo ;
Sandmaier, Brenda M. ;
Barrett, John ;
Blaise, Didier ;
Lowski, Robert ;
Horowitz, Mary .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (12) :1628-1633
[2]   Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation [J].
Baron, F. ;
Labopin, M. ;
Niederwieser, D. ;
Vigouroux, S. ;
Cornelissen, J. J. ;
Malm, C. ;
Vindelov, L. L. ;
Blaise, D. ;
Janssen, J. J. W. M. ;
Petersen, E. ;
Socie, G. ;
Nagler, A. ;
Rocha, V. ;
Mohty, M. .
LEUKEMIA, 2012, 26 (12) :2462-2468
[3]   Syngeneic hematopoietic stem-cell transplantation for Non-Hodgkin's lymphoma: A comparison with allogeneic and autologous transplantation - The lymphoma working committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation [J].
Bierman, PJ ;
Sweetenham, JW ;
Loberiza, FR ;
Taghipour, G ;
Lazarus, HM ;
Rizzo, JD ;
Schmitz, N ;
van Besien, K ;
Vase, JM ;
Horowitz, M ;
Goldstone, A .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (20) :3744-3753
[4]   High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma [J].
Bloor, Adrian J. C. ;
Thomson, Kirsty ;
Chowdhry, Noha ;
Verfuerth, Stephane ;
Ings, Stuart J. ;
Chakraverty, Ranjon ;
Linch, David C. ;
Goldstone, Anthony H. ;
Peggs, Karl S. ;
Mackinnon, Stephen .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (01) :50-58
[5]   Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia [J].
Boyiadzis, Michael ;
Arora, Mukta ;
Klein, John P. ;
Hassebroek, Anna ;
Hemmer, Michael ;
Urbano-Ispizua, Alvaro ;
Antin, Joseph H. ;
Bolwell, Brian J. ;
Cahn, Jean-Yves Y. ;
Cairo, Mitchell S. ;
Cutler, Corey S. ;
Flowers, Mary E. ;
Gale, Robert P. ;
Herzig, Roger ;
Isola, Luis M. ;
Jacobsohn, David A. ;
Jagasia, Madan H. ;
Klumpp, Thomas R. ;
Lee, Stephanie J. ;
Petersdorf, Effie W. ;
Santarone, Stella ;
Spellman, Stephen R. ;
Schouten, Harry C. ;
Verdonck, Leo F. ;
Wingard, John R. ;
Weisdorf, Daniel J. ;
Horowitz, Mary M. ;
Pavletic, Steven Z. .
CLINICAL CANCER RESEARCH, 2015, 21 (09) :2020-2028
[6]   Allogeneic Transplantation for Lymphoma [J].
Chakraverty, Ronjon ;
Mackinnon, Stephen .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (14) :1855-1863
[7]   Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Blood and Marrow Transplantation [J].
Cook, Gordon ;
Smith, Graeme M. ;
Kirkland, Keiren ;
Lee, Julia ;
Pearce, Rachel ;
Thomson, Kirsty ;
Morris, Emma ;
Orchard, Kim ;
Rule, Simon ;
Russell, Nigel ;
Craddock, Charles ;
Marks, David I. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (10) :1419-1427
[8]   Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect [J].
Dodero, A. ;
Spina, F. ;
Narni, F. ;
Patriarca, F. ;
Cavattoni, I. ;
Benedetti, F. ;
Ciceri, F. ;
Baronciani, D. ;
Scime, R. ;
Pogliani, E. ;
Rambaldi, A. ;
Bonifazi, F. ;
Dalto, S. ;
Bruno, B. ;
Corradini, P. .
LEUKEMIA, 2012, 26 (03) :520-526
[9]   Impact of Pretransplantation Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III Follicular Lymphoma [J].
Hamadani, Mehdi ;
Saber, Wael ;
Ahn, Kwang Woo ;
Carreras, Jeanette ;
Cairo, Mitchell S. ;
Fenske, Timothy S. ;
Gale, Robert Peter ;
Gibson, John ;
Hale, Gregory A. ;
Hari, Parameswaran N. ;
Hsu, Jack W. ;
Inwards, David J. ;
Kamble, Rammurti T. ;
Klein, Anderas ;
Maharaj, Dipnarine ;
Marks, David I. ;
Rizzieri, David A. ;
Savani, Bipin N. ;
Schouten, Harry C. ;
Waller, Edmund K. ;
Wirk, Baldeep ;
Laport, Ginna. G. ;
Montoto, Silvia ;
Maloney, David G. ;
Lazarus, Hillard M. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (05) :746-753
[10]   The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research [J].
Horowitz, M. M. .
BONE MARROW TRANSPLANTATION, 2008, 42 (Suppl 1) :S1-S2